Cargando…
Bridging Therapies With Injectable Immunomodulatory Drugs in the Management of Multiple Sclerosis: A Delphi Survey of an Italian Expert Panel of Neurologists
BACKGROUND: In multiple sclerosis (MS), bridging therapies are usually administered when switching from one therapy to another. Such treatments generally consist of injectable immunomodulatory drugs (interferon or glatiramer acetate), whose efficacy, safety, and tolerability data are consolidated fo...
Autores principales: | Marfia, Girolama Alessandra, Centonze, Diego, Salvetti, Marco, Ferraro, Elisabetta, Panetta, Valentina, Gasperini, Claudio, Mirabella, Massimiliano, Conte, Antonella |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9337240/ https://www.ncbi.nlm.nih.gov/pubmed/35911920 http://dx.doi.org/10.3389/fneur.2022.898741 |
Ejemplares similares
-
Predictors of lymphocyte count recovery after dimethyl fumarate-induced lymphopenia in people with multiple sclerosis
por: Lucchini, Matteo, et al.
Publicado: (2021) -
Optimizing the “Time to pregnancy” in women with multiple sclerosis: the OPTIMUS Delphi survey
por: Carbone, Luigi, et al.
Publicado: (2023) -
Digital work engagement among Italian neurologists
por: Brigo, Francesco, et al.
Publicado: (2021) -
Drugs foresight 2020: a Delphi expert panel study
por: Lintonen, Tomi, et al.
Publicado: (2014) -
Immune responses to alglucosidase in infantile Pompe disease: recommendations from an Italian pediatric expert panel
por: Gragnaniello, Vincenza, et al.
Publicado: (2022)